retifanlimabECOG Performance Status
… II multiregional study, evaluated efficacy and tolerability of retifanlimab, a humanized monoclonal antibody targeting programmed cell deat…
2articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Retifanlimab ×
Retifanlimab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Retifanlimab
2 articles · page 1 of 1palbociclibretifanlimabMemorial Sloan Kettering Cancer Centerdedifferentiated liposarcomaDDLPS
…emic therapy prior to surgery, were eligible. Patients received palbociclib (125 mg orally, days 1–21 of a 28-day cycle) plus retifanlimab …